Glucose Monitoring During Chemotherapy

Completed

Conditions studied: Breast Cancer, Hyperglycemia

In brief

This is a research study to look at blood sugar changes during chemotherapy using a continuous blood sugar monitoring device. The device uses patches that attach to the skin on the back of the arm to measure blood sugar changes for the duration of the chemotherapy course. Each patch lasts for about 2-weeks. During chemotherapy visits, new patches will be placed and will be worn until the chemotherapy course is complete. Participants will be in this study for 6 months. Approximately 50 patients will be enrolled in this study.

Key facts

Study ID

NCT04473378

Run by

Columbia University

People needed

22

Starts

2019-10-31

Expected to finish

2022-08-17

Last updated by the study team

2025-01-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥18 years
• History of stage I-III breast cancer
• Patient scheduled to receive adjuvant or neoadjuvant chemotherapy
• Signed informed consent

You may not qualify if…

• Current treatment with insulin
• Current treatment with non-topical steroids, with the exception of steroid treatment as a supportive chemotherapy medication
• Inability to provide informed consent

Where it is running

• Herbert Irving Pavilion — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.